Interestingly, MDSCs can directly block the entry of CD8+ T cells into tumors, by producing high levels of PNT, as well as are able to inhibit T-cell proliferation, strongly impairing the anti-tumor immune response (12, 107). Here, CD8A is linked to neoplasm.